CITALOPRAM HYDROBRO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F0802 to DMS Pharmaceutical Group Inc on August 26, 2026, for the procurement of Citalopram Hydrobromide. This action was issued as a delivery order under the broader base administrative contract SPE2DX25D9900, which was established on April 2, 2025, with a total award value of 19,999,999.00 dollars. Despite the initial award, modification P00001 was issued by DLA Troop Support on August 26, 2026, resulting in a termination for the government's convenience. This modification cancelled line item 0001 at no cost to the government, effectively reducing the total contract value from 3.44 dollars to 0.00 dollars.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
